CompletedPhase 4NCT03521687

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Icahn School of Medicine at Mount Sinai
Principal Investigator
Saakshi Khattri, MD
Icahn School of Medicine at Mount Sinai
Intervention
Apremilast(drug)
Enrollment
20 target
Eligibility
18 years · FEMALE
Timeline
20182021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03521687 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials